TGCT of the shoulder - a case series and literature review.

[Vimseltinib in non-resecable tenosynovial giant cell tumor].

Tenosynovial Giant Cell Tumor With Bone Erosion of the Tibial Midshaft: A Case Report.

Soft tissue and juxtaarticular tumors of the knee.

Bilateral Localized-Tenosynovial Giant Cell Tumor of the Knee: Case Report and Review.

Posterior Knee TGCT (Formerly PVNS) Masquerading as a Popliteal Lesion: Combined Arthroscopic Synovectomy and Posterior Open Excision With 8-Year Disease-Free Follow-Up.

Mixed-Methods to Define Meaningful Change using Exit Interviewand Clinical Trial Data in Patients with Tenosynovial Giant Cell Tumor (TGCT).

Pediatric patients with tenosynovial giant cell tumor: real-world evidence from an observational registry.

High Risk of Drug-Drug Interactions Caused by Pexidartinib via UDP-Glucuronosyltransferases Inhibition.

Open synovectomy for treatment of tenosynovial giant cell tumors of the knee in children.

A rare case report of chondroblastoma like soft tissue chondroma and discussion of its benign mimics.

Management of tenosynovial giant cell tumor: approved and investigational therapies.

Tenosynovial Giant Cell Tumor of the Thumb with Bony Erosion - A Case Report on Surgical Excision with Adjuvant Chemical Cauterization.

Current Treatment Strategies for Diffuse Tenosynovial Giant Cell Tumor: A Review of the Literature.

Imaging findings of intra-articular tumor/tumor-like lesions based on pathologic correlation.

Calcified chondroid mesenchymal neoplasm.

Mechanistic Study of CD90-Positive Synovial Fibroblasts in the Invasion and Recurrence of Pigmented Villonodular Synovitis.

Cystic Lesions of the Hand Skeleton.

The Impact of Osseous Erosions on Intraarticular Tenosynovial Giant Cell Tumors of the Knee and Local Recurrence.

Multifocal tenosynovial giant cell tumor: A case report.

[Localized tenosynovial giant cell tumor of the knee. Case report].

Knowledge map of recurrence in tenosynovial giant cell tumor: a bibliometric analysis.

Genicular Embolization as a Therapeutic Alternative in Tenosynovial Giant Cell Tumor: A Case Report.

Uncommon Localization of Tenosynovial Giant Cell Tumor in the Coracoclavicular Ligament: Diagnostic Challenges.

Tenosynovial Giant Cell Tumors: A Musculoskeletal Case Series.

Giant Cell-Rich Tumors of Bone and Soft Tissue.

PIGMENTED VILLONODULAR SYNOVITIS IN THE ANKLE OF A PEDIATRIC PATIENT: A CASE REPORT.

Temporomandibular Joint Lesions with Intracranial Extension: Illustrative Cases from a Systematic Review of the Literature and Our Institution.

MRI Radiomics for Predicting the Diffuse Type of Tenosynovial Giant Cell Tumor: An Exploratory Study.

Tenosynovial giant cell tumour in children. Our experience with 24 patients in a third level Children's Hospital, an observational study.

Tenosynovial giant cell tumor (TGCT): Mechanisms and advances in targeted treatments.

Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor.

Adverse events of pexidartinib for the treatment of TGCT: a real-world disproportionality analysis using FDA Adverse Event Reporting System database.

Proteomics and metabolomics studies in pigmented villonodular synovitis uncover the regulation of monocyte differentiation by the ADGRE5-NF-κB pathway.

[MRI in tenosynovial giant cell tumor (TGCT) - (formerly pigmented villonodular synovitis - PVNS)].

A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system.

Diagnosis and Treatment Options in Pigmented Villonodular Synovitis of the Knee: A Narrative Review.

A Phase 3 Study of the Efficacy and Safety of Pexidartinib in East Asian Patients with Tenosynovial Giant Cell Tumor.

Primary tenosynovial giant cell tumor arising in the nasal cavity with molecular confirmation: the first reported case.

Don't Dismiss the Swelling: A Rare Case of Tenosynovial Giant Cell Tumor in a Young Woman's Finger - A Case Report.

Tenosynovial giant cell tumor and its differential diagnosis in children.

Giant Cell Tumor of Hoffa's Fat Pad: A Case Report.

Real-world experience of patients newly initiated on pexidartinib for tenosynovial giant cell tumor.

Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study.

Tenosynovial Giant Cell Tumors of the Hand: Analysis of Risk Factors for Surgical Margin and Recurrence.

Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: Clinical Course After Anterior Open Synovectomy.

Characterizing the metabolites of the tyrosine-kinase inhibitor pexidartinib in mouse feces, urine, plasma, and liver.

The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review.

Chondroid Diffuse Tenosynovial Giant Cell Tumor of the Temporomandibular Joint: A Case of a Rare Maxillofacial Tumor With Unique Pathophysiology and Therapeutic Considerations.

Microsurgical resection of tenosynovial giant cell tumor in the digits microsurgery for digital GCT.

Single-Cell RNA Sequencing Study on Two Synovial Derived Tumors in the Temporomandibular Joint.

Vimseltinib: A novel colony stimulating factor 1 receptor (CSF1R) inhibitor approved for treatment of tenosynovial giant cell tumors (TGCTs).

TURALIO® Risk Evaluation and Mitigation Strategy (tREMS) program: 5-year retrospective hepatic safety assessment.

Pigmented villonodular synovitis of the temporomandibular joint. evaluation of 12 patients from 2017 to 2023.

Medical Management of Tenosynovial Giant Cell Tumor.

A Novel Case of Tenosynovial Giant Cell Tumor at 4 Years After Total Knee Arthroplasty for Medial Osteoarthritis With Synovial Osteochondromatosis.

Case Report: Giant cell lesions in the Maxillofacial region: diagnostic points and treatment strategies.

MR Imaging Features of Malignant Tenosynovial Giant Cell Tumors.

Large Tenosynovial Giant Cell Tumor Treated with Hip Arthroscopy in the Setting of Osteoarthritis: 13-Year Outcomes with Annual MRI Surveillance: A Case Report.

A Case Report on an Uncommon Presentation of Giant Cell Tumor of the Tendon Sheath in the Infrapatellar Region.

Vimseltinib (Romvimza) for tenosynovial giant cell tumor.

Tenosynovial Giant Cell Tumor Involving Quadriceps Muscle - A Case Report of Two Cases.

Localized and diffuse tenosynovial giant cell tumor: real-world results from a patient observational registry.

Patient-reported continued benefits of pexidartinib for tenosynovial giant cell tumor based on a real-world study in the United States.

Advancing Preoperative Diagnosis: Case Report and Imaging Analysis of Cervical Spine Tenosynovial Giant Cell Tumor.

Tenosynovial giant cell tumor as an uncommon cause of persistent hip pain.

Nosologic Reappraisal of the Recently Proposed Calcified Chondroid Mesenchymal Neoplasm Concept in a Series of 20 Cases.

Tenosynovial Giant Cell Tumor and Pigmented Villonodular Synovitis.

Single-Cell Analysis Clarifies Pathological Heterogeneity in Tenosynovial Giant Cell Tumor and Identifies Biomarkers for Predicting Disease Recurrence.

Recurrent diffuse tenosynovial giant cell tumor of the posterior knee: a rare presentation with synovial herniation (Baker's cyst) in a young patient.

Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib.

Mismatch Between Preoperative MRI Findings and Postoperative Histological Results in the Treatment of Tenosynovial Giant Cell Tumor.

Therapeutic advances in Tenosynovial giant cell Tumor: Targeting the CSF1/CSF1R axis.

An evaluation of vimseltinib for treatment of tenosynovial giant cell tumors.

Fibroma of Tendon Sheath Revisited.

A Rare Cutaneous Presentation of Malignant Tenosynovial Giant Cell Tumor.

Diagnostic Challenge of Localized Tenosynovial Giant Cell Tumor in Children.

Giant Cell Tumor of Flexor Tendon Sheath: An Interesting Clinical Presentation as Subungual Growth.

Recent advances in immunohistochemical and molecular profiling for differential diagnosis between giant cell-rich lesions and tenosynovial giant cell tumors.

Peficitinib suppresses diffuse-type tenosynovial giant cell tumor by targeting TYK2 and JAK/STAT signaling.

Recurrent Diffuse Tenosynovial Giant Cell Tumor of the Temporomandibular Joint.

Treatment of Tenosynovial Giant Cell Tumor of the Cervical Spine with Postoperative Anti-RANKL Antibody (Denosumab) Administration.

Emerging therapeutics in the management of tenosynovial giant cell tumor (TGCT).

Tenosynovitis with psammomatous calcifications: Series of 18 cases and review of the literature emphasizing a common source of expert consultation and updated differential diagnosis.

A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib.

Is intercalary frozen autograft augmented with intramedullary cement and bridging plates fixation a durable reconstruction?

Treatment Modalities for Refractory-Recurrent Tenosynovial Giant Cell Tumor (TGCT): An Update.

Chronic hearing loss turns out being a calcified chondroid mesenchymal neoplasm with FN1::FGFR2 fusion.

Case report: Tenosynovial giant cell tumor.

Vimseltinib versus a placebo in patients with tenosynovial giant cell tumor: a plain language summary of the MOTION phase 3 trial.

Patient Outcomes After Resection of Pigmented Villonodular Synovitis in Patients in King Abdulaziz Medical City.

Localized type tenosynovial giant cell tumor with metastases to lungs and pleura: a case report and literature review.

[Synovial chondromatosis : Results from the histopathological arthritis register of the German Society for Orthopedic Rheumatology].

MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients.

Atypical Presentation of Tenosynovial Giant Cell Tumor on the Hallucal Flexor Tendon Sheath: A Case Report.

Chondroid Synoviocytic Neoplasm: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of a Distinctive Tumor of Synoviocytes.

Malignant tenosynovial giant cell tumor: A case report.

Pexidartinib Upfront in a Case of Tenosynovial Giant Cell Tumor: Proof of Concept for a Treatment Paradigm Shift.

Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies.

Tenosynovial Giant Cell Tumor in the Gruberi Bursa.

Multiportal Arthroscopy-assisted Surgical Resection of Diffuse-type Tenosynovial Giant Cell Tumors in the Ankle Joint Yields Favorable Clinical Outcomes: A Retrospective Study.

Localized Tenosynovial Giant Cell Tumor After Total Knee Arthroplasty.

Peripheral Vascular Compression in a Patient With Diffuse Tenosynovial Giant Cell Tumor of the Knee: A Case Report Focusing on the Role of the Ultrasound.

TURALIO® Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment.

ISLET-1 expression in soft tissue neoplasms reveals high sensitivity but moderate specificity for desmoplastic small round cell tumors and potential utility as a diagnostic biomarker.

Comprehensive Molecular Characterization of a Large Series of Calcified Chondroid Mesenchymal Neoplasms Widening Their Morphologic Spectrum.

CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib.

Fine-needle aspiration cytology of diffuse type tenosynovial giant cell tumor with malignant trasformation and review of literature.

Cytoplasmic PPARγ Significantly Correlates With P53 Immunohistochemical Expression and Tumor Size in Localized Tenosynovial Giant Cell Tumor.

Incidental Abdominal Wall Endometriosis in Plastic Surgery: Two Cases and Review of the Literature.

Giant Cell Tumor of Soft Tissue: An Updated Review.

Tenosynovial giant cell tumor: case report and molecular investigation.

Giant Cell Tumor in Tarsal Midfoot Bones: A Case Report.

Case report: Primary sarcoma of the mandible with a novel SLMAP-BRAF fusion.

Recurrent Localized Tenosynovial Giant Cell Tumor of the Left Ring Finger: A Case Report and Literature Review.

MRgFUS ablation of a recurrent tenosynovial giant cell tumor in the foot using ExAblate 2100 system in combination with patient immobilization device.

Thighplasty at the Time of Stage-1 Bone-Anchored Osseointegration Surgery.

Intra-Articular Nodular Fasciitis of the Knee, A Rare Clinical Presentation and Histological Diagnosis: A Case Report.

Invasion Patterns and Long-Term Clinical Outcomes of Diffuse Tenosynovial Giant Cell Tumor of the Ankle Joint.

A Case Report of Diffuse-type Tenosynovial Giant Cell Tumor as a Calcaneus Mass: A Diagnostic Challenge.

Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug Exposure.

Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA.

Calcified Chondroid Mesenchymal Neoplasms.

Histiocytic sarcoma mimicking localized tenosynovial giant cell tumor in the pediatric foot: A rare case report with MRI Findings.

Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?

Arthroscopic Excision of a Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report.

Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study.

A Rare Case of Giant Cell Tumour of Tendon Sheath and Its Arthroscopic In Toto Excision.

Unmasking Coincident Hodgkin Lymphoma and Giant Cell Tumor: Insights from [18F] FDG PET/CT.

Medium-term Outcomes of Excision Using Surgical Microscope of Tenosynovial Giant Cell Tumors of the Hand.

What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?

[Diagnosis and management of tenosynovial giant cell tumor].

Exploring the Effect of Compound Glycyrrhizin and Silybinin on the Metabolism of Pexidartinib in Rats Based on CYP3A4 and CYP2C9.

Computational exploration of the significance of COPS6 in cancer: Functional and clinical relevance across tumor types.

Oncological and functional outcomes of modified arthroscopic resection for intra-articular tenosynovial giant cell tumor of the knee using multiple portals.

Unveiling the Enigma: Uncommon Hand Giant Cell Tumor within the Tendon Sheath.

Uncommon Presentation of a Giant Cell Tumor of the Tendon Sheath of the Hand: A Case Report.

A Rare Clinical Presentation With a Difficult Imaging Diagnosis of an Intra-articular Clear Cell Sarcoma of the Knee.

CSF1 expression in xanthogranulomatous epithelial tumor/keratin-positive giant cell-rich tumor.

Outcomes of arthroscopic elbow synovectomy and neurolysis of the ulnar nerve for tenosynovial giant cell tumor in a young athlete: a case report and literature review.

Synovial chondromatosis: Rare involvement of metacarpophalangeal joint and diagnostic challenges in MR imaging.

Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint.

Real-World Patient Experience of Pexidartinib for Tenosynovial Giant-Cell Tumor.

Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team.

Localized tenosynovial giant cell tumor in children.

Tenosynovial giant cell tumor: a case report.

Bone SPECT/CT in Advanced Diffuse Tenosynovial Giant Cell Tumor of the Wrist.

1HNMR-based serum metabolomic profiling for patients with diffuse-type tenosynovial giant cell tumor.

Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case.

Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.

[Localized tenosynovial giant cell tumor : Results from the Histopathological Arthritis Register of the German Society for Orthopedic Rheumatology].

The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor.

Recurrent diffuse tenosynovial giant cell tumor of the knee treated with adjuvant radiotherapy: A case report.

Distal Dorsal Thumb Mass: Giant Cell Tumor of the Tendon Sheath in an Unusual Location.

Current therapies and future prospective for locally aggressive mesenchymal tumors.

Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets.

Identifying the Reactive Metabolites of Tyrosine Kinase Inhibitor Pexidartinib In Vitro Using LC-MS-Based Metabolomic Approaches.

Imaging characteristics of tenosynovial giant cell tumors on 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a retrospective observational study.

Surgical Techniques and Functional Reconstruction for Complex Tenosynovial Giant Cell Tumor of Temporal Bone and Middle Skull Base.

T2-star (T2*)-weighted magnetic resonance imaging of tenosynovial giant cell tumors.

Diffuse Tenosynovial Giant Cell Tumor Encircling the First Metatarsal Bone Remodeling after Resection. A Case Report.

Updates on the Treatment of Tenosynovial Giant Cell Tumor.

Prediction of local recurrence in tenosynovial giant cell tumor of the knee: Based on preoperative MRI evaluation into disease subtypes and severity.

Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment.

Total Synovectomy and Bone Grafting/Cementation after Curettage of the Bone Lesion in Diffuse‏ Type ‏of Tenosynovial‏ Giant Cell Tumor‎: A Retrospective Cohort Study.

T2 Black Synovitis in Musculoskeletal MRI: Disease Spectrum and Imaging Characteristics of Joint Diseases.

A rare case of long-term joint swelling caused by pigmented villonodular synovitis in a 3-year-old girl: a case report.

Understanding the Effect of Osteoarthritis on Surgical Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients With Tenosynovial Giant Cell Tumors.

Arthroscopic resection of localized tenosynovial giant cell tumor in the deep infrapatellar bursa: a case report.

18F-FDG PET/CT image of tenosynovial giant cell tumor in the thoracic vertebra.

Image findings of tendon sheaths affected by diffuse tenosynovial giant cell tumors of the skull base.

Dosing Recommendation Based on the Effects of Different Meal Types on Pexidartinib Pharmacokinetics in Healthy Subjects: Implementation of Model-informed Drug Development Strategy.

Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan.

Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.

Effectiveness of arthroscopic excision based on the distribution of the tenosynovial giant cell tumor around knee joint.

Presurgical Perspective and Posttreatment Evaluation of Soft Tissue Tumors of the Ankle and Foot in Adults.

Presurgical Perspective and Postsurgical Evaluation of Morton's Neuroma and Other Nerve Lesions.

One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study.

MRI Prediction Model for Tenosynovial Giant Cell Tumor with Risk of Diffuse-type.

Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).

Surgical treatment of spinal tenosynovial giant cell tumor: Experience from a single center and literature review.

Incidental Detection of a Tenosynovial Giant Cell Tumor of the Thigh on [68Ga]Ga-FAPI PET/CT: Presentation of an Unusual Case.

Exploration of comorbidity mechanisms and potential therapeutic targets of rheumatoid arthritis and pigmented villonodular synovitis using machine learning and bioinformatics analysis.

Intra-Articular Tenosynovial Giant Cell Tumor Mimicking Septic Arthritis: A Report of Two Cases.

Outcomes of Surgical Treatment for Localized Tenosynovial Giant-Cell Tumor of the Foot and Ankle: A Case Series.

Radiological and pathological characteristics of synovial hemangioma of the knee.

Complementary Effects of Surgery and Pexidartinib in the Management of Patients with Complex Diffuse-Tenosynovial Giant Cell Tumor.

A novel colony-stimulating factor 1 (CSF1) translocation  involving human endogenous retroviral element in a tenosynovial giant cell tumor.

Role of colony-stimulating factor 1 in the neoplastic process of tenosynovial giant cell tumor.

Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy.

Lateral T-Capsulotomy with Hip Arthroscopy for Access and Excision of Posterior Intra-Articular Mass.

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis.

Expanding the molecular spectrum of tenosynovial giant cell tumors.

Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: A case report.

Localized Pigmented Villonodular Synovitis of the Knee Joint: A Case Report.

CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.

Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.

FNAC study of giant cell tumor of tendon sheath (localized tenosynovial giant cell tumor): Clinico-radiological correlation and cytopathological features.